Method and assay for determining FAS expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 1, 2014
Issued Date -
N/A
app pub date -
Aug 26, 2010
filing date -
Aug 27, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods and immunoassays for the determination of fatty acid synthase (FAS) expression in patients having or suspected of having a proliferative disorder, especially prostate cancer, are disclosed. The sensitive method and assay detect the level of expression of FAS in a biological sample using antibodies that are highly specific for FAS. The method and assay can be used to monitor the progression of cancer, and/or to predict the efficacy of certain treatments or the likelihood of recurrence of the cancer.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully